Kineta(KA)
Search documents
Kineta(KA) - 2020 Q4 - Annual Report
2021-03-31 12:59
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38549 YUMANITY THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) | Delaware 20-8436652 | | | --- | --- | | ( ...
Kineta(KA) - 2020 Q3 - Quarterly Report
2020-11-16 21:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37695 Proteostasis Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or Other jurisdiction of Incorpora ...
Kineta(KA) - 2020 Q2 - Quarterly Report
2020-08-06 20:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37695 Proteostasis Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or Other jurisdiction of Incorporation ...
Kineta(KA) - 2020 Q1 - Quarterly Report
2020-05-15 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37695 Proteostasis Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 20-8436652 (State or Other jurisdict ...
Kineta(KA) - 2019 Q4 - Annual Report
2020-03-10 20:37
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37695 PROTEOSTASIS THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 20-8436652 (State or Other Jur ...
Kineta(KA) - 2019 Q3 - Quarterly Report
2019-11-07 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37695 Proteostasis Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 20-8436652 (State or other juris ...
Kineta(KA) - 2019 Q2 - Quarterly Report
2019-08-07 20:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37695 Proteostasis Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 20-8436652 (State or other jurisdicti ...
Kineta(KA) - 2019 Q1 - Quarterly Report
2019-05-08 21:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37695 Proteostasis Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 20-8436652 (State or other jurisdict ...
Kineta(KA) - 2018 Q4 - Annual Report
2019-03-08 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37695 PROTEOSTASIS THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 20-8436652 (State or Other Jur ...